Your members already want GLP-1s, peptide therapy, hormone optimization, and longevity protocols. They're getting them elsewhere — usually from telehealth companies you've never heard of. Build.MD lets you offer them under your brand, clinically supervised.
The demand exists inside your base today. Conversion is the only variable.
Drag your membership base. We model a conservative 5% conversion to active Rx patients.
Drag your membership base. We model a 5% conversion to active Rx patients.
Conservative 5% of members opt into an Rx program. Industry benchmarks run 4–8%.
You stay close to your patients and your brand. We run the clinical and operational backbone underneath.
How operators like you use Build.MD. Customer names available under NDA; examples are illustrative.
ChallengeMembers were buying peptides and GLP-1s from random telehealth sites.
ApproachBranded Rx programs with eligibility checks and provider oversight.
ChallengeHigh-intent members wanted TRT and longevity with nowhere in-house.
ApproachPhysician-supervised protocols offered under the studio's brand.
ChallengeLarge audience, no clinical infrastructure or licensing.
ApproachWhite-labeled intake and Rx wired into the existing member app.
We're onboarding a small first cohort. Tell us what you're building — we'll confirm fit before either of us spends more time.
Build.MD is in early access. We're working with a focused group of operators across providers, medspas, fitness, brands, and enterprise before opening broadly. Tell us what you're building; we'll come back within the next business day if there's a fit.